CoChat

Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020

Open access

The DOI matches its Crossref record; 297 of the 302 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

HEPATITIS A IS A VACCINE-PREVENTABLE, COMMUNICABLE DISEASE OF THE LIVER CAUSED BY THE HEPATITIS A VIRUS (HAV). THE INFECTION IS TRANSMITTED VIA THE FECAL-ORAL ROUTE, USUALLY FROM DIRECT PERSON-TO-PERSON CONTACT OR CONSUMPTION OF CONTAMINATED FOOD OR WATER. HEPATITIS A IS AN ACUTE, SELF-LIMITED DISEASE THAT DOES NOT RESULT IN CHRONIC INFECTION. HAV ANTIBODIES (IMMUNOGLOBULIN G [IGG] ANTI-HAV) PRODUCED IN RESPONSE TO HAV INFECTION PERSIST FOR LIFE AND PROTECT AGAINST REINFECTION; IGG ANTI-HAV PRODUCED AFTER VACCINATION CONFER LONG-TERM IMMUNITY. THIS REPORT SUPPLANTS AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMENDATIONS FROM THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) REGARDING THE PREVENTION OF HAV INFECTION IN THE UNITED STATES. ACIP RECOMMENDS ROUTINE VACCINATION OF CHILDREN AGED 12-23 MONTHS AND CATCH-UP VACCINATION FOR CHILDREN AND ADOLESCENTS AGED 2-18 YEARS WHO HAVE NOT PREVIOUSLY RECEIVED HEPATITIS A (HEPA) VACCINE AT ANY AGE. ACIP RECOMMENDS HEPA VACCINATION FOR ADULTS AT RISK FOR HAV INFECTION OR SEVERE DISEASE FROM HAV INFECTION AND FOR ADULTS REQUESTING PROTECTION AGAINST HAV WITHOUT ACKNOWLEDGMENT OF A RISK FACTOR. THESE RECOMMENDATIONS ALSO PROVIDE GUIDANCE FOR VACCINATION BEFORE TRAVEL, FOR POSTEXPOSURE PROPHYLAXIS, IN SETTINGS PROVIDING SERVICES TO ADULTS, AND DURING OUTBREAKS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.rr6905a1

Cites

297 of 298 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Number of reported and estimated hepatitis A cases — United States, 2013–2017 Source: CDC, National Notifiable Diseases Surveillance System. Surveillance for viral hepatitis—United States, 2017. Atlanta, GA: CDC, US Department of Health and Human Services. https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm
FIGURE 1 Number of reported and estimated hepatitis A cases — United States, 2013–2017 Source: CDC, National Notifiable Diseases Surveillance System. Surveillance for viral hepatitis—United States, 2017. Atlanta, GA: CDC, US Department of Health and Human Services. https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htmCC BY · PubMed Central
FIGURE 2 Immunologic and clinical events associated with hepatitis A virus infection and recovery Source: CDC. Diagnosis and management of foodborne illnesses. MMWR Recomm Rep 2004;53(No. RR-4). Abbreviations: ALT = alanine aminotransferase; HAV = hepatitis A virus; IgG = immunoglobulin G; IgM = immunoglobulin M.
FIGURE 2 Immunologic and clinical events associated with hepatitis A virus infection and recovery Source: CDC. Diagnosis and management of foodborne illnesses. MMWR Recomm Rep 2004;53(No. RR-4). Abbreviations: ALT = alanine aminotransferase; HAV = hepatitis A virus; IgG = immunoglobulin G; IgM = immunoglobulin M.CC BY · PubMed Central
FIGURE 3 Estimated age at midpoint of population immunity* to hepatitis A, by country — 2015 Source: Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med 2018;8:a031716. Abbreviations: AMPI = age at midpoint of population immunity; HAV = hepatitis A virus. * The AMPI is the youngest age at which half of the birth cohort has serologic evidence of previous exposure to HAV. As the AMPI increases (light to dark), the endemicity level of hepatitis A generally decreases.
FIGURE 3 Estimated age at midpoint of population immunity* to hepatitis A, by country — 2015 Source: Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med 2018;8:a031716. Abbreviations: AMPI = age at midpoint of population immunity; HAV = hepatitis A virus. * The AMPI is the youngest age at which half of the birth cohort has serologic evidence of previous exposure to HAV. As the AMPI increases (light to dark), the endemicity level of hepatitis A generally decreases.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. Favero MSBW. Disinfection and sterilization. In: Zuckerman AJ TH, ed. Viral hepatitis, scientific basis and clinical management. New York: Churchill Livingstone; 1993. pp. 565–75.
  2. Nelson N. Hepatitis A. CDC yellow book 2020. New York, NY: Oxford University Press; 2020.
  3. Knopf-Amelung S. Incarceration and homelessness: a revolving door of risk. In Focus: A Quarterly Research Review of the National Health Care for the Homeless Council 2013;2:5. https://nhchc.org/wp-content/uploads/2019/08/infocus_incarceration_nov2013.pdf
  4. Safran R. Hepatitis A/B prevention at Washington State Penitentiary. J Investig Med 2010; 58: 242– 3.
  5. CDC. FDA approval of an alternate dosing schedule for a combined hepatitis A and B vaccine (Twinrix®). MMWR Morb Mortal Wkly Rep 2007; 56: 1057.
  6. Nelson NP, Link-Gelles R, Hofmeister MG, Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morb Mortal Wkly Rep 2018; 67: 1216– 20. 10.15585/mmwr.mm6743a5 30383742 PMC6319798 · DOI
  7. Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med [Review]. 2018;8:01. PMC6169986 29500305 · DOI · Paper page
  8. Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr 2011; 10: 57. 10.1186/1476-072X-10-57 22008459 PMC3210090 · DOI
  9. Nelson NP. Updated dosing instructions for immune globulin (human) GamaSTAN S/D for hepatitis A virus prophylaxis. MMWR Morb Mortal Wkly Rep 2017; 66: 959– 60. 10.15585/mmwr.mm6636a5 28910270 PMC5657912 · DOI
  10. Nelson NP, Link-Gelles R, Hofmeister MG, Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morb Mortal Wkly Rep 2018; 67: 1216– 20. 10.15585/mmwr.mm6743a5 30383742 PMC6319798 · DOI
  11. Link-Gelles R, Hofmeister MG, Nelson NP. Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use. Vaccine 2018; 36: 2745– 50. 10.1016/j.vaccine.2018.04.015 29673941 · DOI
  12. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis 2004; 38: 705– 15. 10.1086/381671 14986256 · DOI · Paper page
  13. Staes CJ, Schlenker TL, Risk I, Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 2000; 106: E54. 10.1542/peds.106.4.e54 11015549 · DOI
  14. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992; 10(Suppl 1): S15– 7. 10.1016/0264-410X(92)90533-P 1335649 · DOI · Paper page
  15. Sharapov UM, Kentenyants K, Groeger J, Roberts H, Holmberg SD, Collier MG. Hepatitis A infections among food handlers in the United States, 1993–2011. Public Health Rep 2016; 131: 26– 9. 10.1177/003335491613100107 26843666 PMC4716468 · DOI
  16. Morey RJ, Collier MG, Nelson NP. The financial burden of public health responses to hepatitis A cases among food handlers, 2012–2014. Public Health Rep 2017; 132: 443– 7. 10.1177/0033354917710947 28609202 PMC5507430 · DOI
  17. Ridpath A, Reddy V, Layton M, Hepatitis A cases among food handlers: a local health department response—New York City, 2013. J Public Health Manag Pract 2017; 23: 571– 6. 10.1097/PHH.0000000000000526 28166179 PMC6951794 · DOI
  18. Hofmeister MG, Foster MA, Montgomery MP, Gupta N. Notes from the field: assessing the role of food handlers in hepatitis A virus transmission—multiple states, 2016–2019. MMWR Morb Mortal Wkly Rep 2020; 69: 636– 7. 10.15585/mmwr.mm6920a4 32437339 · DOI
  19. Rosenblum LS, Villarino ME, Nainan OV, Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991; 164: 476– 82. 10.1093/infdis/164.3.476 1651359 · DOI · Paper page
  20. Noble RC, Kane MA, Reeves SA, Roeckel I. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 1984; 252: 2711– 5. 10.1001/jama.1984.03350190013011 6492349 · DOI
  21. Foster MA, Weil LM, Jin S, Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation. Emerg Infect Dis 2017; 23: 590– 6. 10.3201/eid2304.161532 28322704 PMC5367420 · DOI
  22. Klein BS, Michaels JA, Rytel MW, Berg KG, Davis JP. Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA 1984; 252: 2716– 21. 10.1001/jama.1984.03350190018012 6492350 · DOI

Cited by

See all 279

Metadata

Authors
Nelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., Schillie, S., & Harris, A. M.
Affiliations
  • National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
  • Vanderbilt University (US)
  • Centers for Disease Control and Prevention (US)
  • University of Arkansas for Medical Sciences (US)
Corresponding author
Nelson, Noele P.
Venue
MMWR. Recommendations and Reports
Published
2020-07-03
Volume
69
Issue
5
Pages
1-38
ISSN
  • 1057-5987 (ISSN-L)
  • 1545-8601
OpenAlex
W3038438460
Cited by
264
References
302
Citations by year
2026: 35 · 2025: 43 · 2024: 45 · 2023: 52 · 2022: 41 · 2021: 42 · 2020: 5
FWCI
20.57
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • MMWR Recommendations and Reports (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Centers for Disease Control and Prevention
  • National Center for Immunization and Respiratory Diseases
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Keywords
hepatitis A virus, hepatitis A vaccination, vaccine recommendations, routine childhood immunization, catch-up vaccination, high-risk adults, pre-travel vaccination, post-exposure prophylaxis, anti-HAV IgG, fecal-oral transmission
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Hepatitis A, Humans, Immunization, Infant, United States, Practice Guidelines as Topic, Hepatitis A Vaccines, Advisory Committees

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.